VLN Insider Notice: 1.42M Shares Proposed for Sale via Oppenheimer ($2.88M)

Rhea-AI Filing Summary

Valens Semiconductor Ltd. (VLN) Form 144 discloses a proposed sale of 1,422,700 common shares through Oppenheimer & Co., with an aggregate market value of $2,882,247.93. The filing lists an approximate date of sale of 08/08/2025 and the securities exchange as NYSE. The shares were acquired in a private placement on 01/01/2020.

The notice also reports securities sold during the past three months: Linse Capital LLC sold 1,523,723 common shares on 05/23/2025 for gross proceeds of $3,443,387.00. The filing includes broker details and the filer’s representation that no undisclosed material adverse information is known.

Positive

• None.

Negative

• Proposed sale: 1,422,700 common shares with aggregate market value of $2,882,247.93 (approximate sale date 08/08/2025)
• Recent prior sale disclosed: Linse Capital LLC sold 1,523,723 common shares on 05/23/2025 for gross proceeds of $3,443,387.00

Insights

Securities Analyst

TL;DR Proposed sale of 1,422,700 shares and recent 1,523,723-share disposition are disclosed; note sizes and reported proceeds.

The filing clearly identifies a proposed disposition of 1,422,700 common shares through Oppenheimer & Co. at an aggregate market value of $2,882,247.93 with an approximate sale date of 08/08/2025. It also documents a recent sale by Linse Capital LLC of 1,523,723 shares on 05/23/2025 for $3,443,387.00. These are explicit transaction disclosures under Rule 144 and provide concrete quantities and proceeds that market participants can use to track insider/affiliate selling activity. The filing does not include price-per-share or the filer’s identifying CIK in the provided text.

Corporate Governance Expert

TL;DR Form 144 presents required sale disclosure with acquisition source, broker, and the filer’s certification regarding material undisclosed information.

The document records that the securities were acquired via a private placement on 01/01/2020 and that the proposed sale will be executed through Oppenheimer & Co. It includes the standard signature representation that the filer does not possess undisclosed material adverse information about the issuer. The filing captures necessary compliance elements for a Rule 144 notice but does not supply additional context about the filer’s identity within the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Oppenheimer & Co, Inc 85 Broad St New York NY 10004	1422700	2882247.93	106342415	08/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2020	private placement	issuer			1422700	01/01/2020	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Linse Capital LLC 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Common	05/23/2025	1523723	3443387.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many shares is Valens (VLN) proposing to sell according to this Form 144?

The filing lists a proposed sale of 1,422,700 common shares.

What is the aggregate market value of the shares proposed for sale in the VLN Form 144?

The aggregate market value reported is $2,882,247.93.

Through which broker and on which exchange will the VLN shares be sold?

The broker listed is Oppenheimer & Co., Inc. and the exchange is the NYSE.

When were the securities being offered for sale originally acquired?

The securities were acquired in a private placement on 01/01/2020.

Did the Form 144 disclose any sales in the past three months for VLN?

Yes. It discloses that Linse Capital LLC sold 1,523,723 common shares on 05/23/2025 for $3,443,387.00.